3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
HER2-positive Breast Cancer
1
Interventions
Trastuzumab
4
pertuzumab
2
Docetaxel
2
palbociclib
1
Protons
1
Paclitaxel
1
Letrozole
1
Fulvestrant
1
Enfuvirtide
1
Doxorubicin
1
Cyclophosphamide
1
Capecitabine
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
HER2-positive Breast Cancer
×
Enfuvirtide
×
Clear all
NCT02379585
2018-04-24
STEFNE
Western Regional Medical Center
Phase 1/2
Terminated
8 enrolled
1 chart